Achema middle east

Press Releases

Biovista expands Project Prodigy collaborations in personalized medicine

Biovista announced that it is collaborating with HPE to advance Biovista’s Project Prodigy Big Data AI healthcare platform applied in the personalized medicine vertical.  Advances from the HPE-Biovista collaboration will be used initially within the context of...

The Great Hall of China: double digit growth at CPhI China

P-MEC China, CPHI china , UBM Sinoexpo,CCCMHPIE,Chinese pharmaceutical market development,Asia’s largest pharma event CPhI and P-MEC China, organised by UBM EMEA, UBM Sinoexpo and China Chamber of Commerce for Import & Export of Medicines & Health Products (CCCMHPIE), closed in...

CRL from the FDA for latanoprostene bunod ophthalmic solution , received by Valeant Pharmaceuticals

Valeant Pharmaceuticals International, Inc announced it has received a CRL from the U.S. FDA regarding the NDA for latanoprostene bunod ophthalmic solution, 0.024%, an investigative intraocular pressure lowering single-agent eye drop for patients with open angle glaucoma or ocular...

TrialScope Launches New SaaS Clinical Trial Disclosure Management Tool: Core Disclosure

TrialScope, the global leader in clinical trial transparency and compliance solutions announced the launch of its newest solution, Core Disclosure.  Promoting a new level of data efficiency accuracy and alignment, Core Disclosure enables teams to approve disclosure content once...

Clinerion’s Patient Recruitment System Platform Joined By Baskent University

Başkent University’s hospital cluster is joining the Patient Recruitment System platform, giving their 4.5 M patients access to innovative treatments and therapies offered by cutting edge clinical research.   Başkent University has its headquarters in Ankara....

Priorclave  announce Printer up-grade on lab autoclaves,improving customer experience

Now available on all new laboratory autoclaves and research grade sterilisers leaving the Priorclave production where a printer is required will benefit from inclusion of a new thermal printer.   It offers significant improvements such a...

RedHill Biopharma Announces Positive and Unanimous DSMB Recommendation for Continuation of Phase III Study with RHB-104 for Crohn’s Disease

RedHill Biopharma Ltd. , a specialty biopharmaceutical company primarily focused on late clinical-stage development and commercialization of proprietary, orally-administered, small molecule drugs for gastrointestinal and inflammatory diseases and cancer, today reported, following a second pre-planned meeting to assess the...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »